News UK team awarded grant for ‘second wave’ COVID-19 drug hunt A UK research group has been given £2.2 million in funding to seek out additional drugs to treat COVID-19, in case the first wave of therapies fail to show a benefit.
Events Partner Content 5th Microbiome Movement - Drug Development Summit - Digital ... Attend the Microbiome Movement Drug Development Summit
Events Partner Content 3rd Chronic Kidney Disease Drug Development (CKD3) Summit Advance Therapeutics for Chronic Kidney Diseases
Events Partner Content PREDiCT: Imaging Modalities for Oncology Drug Development Guiding Your Strategic Approach of Multimodal Imaging
Events Partner Content 4th Microbiome Movement - Drug Development Europe Summit Microbiome Movement - Drug Development Europe Summit
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
